Fu Ren
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
- Kruppel-like factors research 3
- Epigenetics and DNA Methylation 3
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Co-authors
- Changyong Li (3 shared papers)Qingyun Du (4 shared papers)Da-Hua Liu (8 shared papers)Xinyue Ye (2 shared papers)Ning Li (3 shared papers)Chao Wu (2 shared papers)Lihua Li (2 shared papers)Shuang Pan (3 shared papers)
- Journals
- International Journal of Oncology (2 papers)ISPRS International Journal of Geo-Information (2 papers)Scientific Reports (1 paper)American Journal of Forensic Medicine & Pathology (1 paper)New Journal of Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Fu Ren
59 papers receiving 765 citations
Peers
Comparison fields: 5 of 140
- Cancer Research 170
- Aging 16
- Geriatrics and Gerontology 23
- Molecular Biology 321
- Oncology 86
Countries citing papers authored by Fu Ren
This map shows the geographic impact of Fu Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Ren more than expected).
Fields of papers citing papers by Fu Ren
This network shows the impact of papers produced by Fu Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Ren. The network helps show where Fu Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 50 | |
| 2 | 2020 | 42 | |
| 3 | 2013 | 40 | |
| 4 | 2009 | 38 | |
| 5 | 2013 | 37 | |
| 6 | 2018 | 34 | |
| 7 | 2018 | 34 | |
| 8 | 2018 | 32 | |
| 9 | 2013 | 32 | |
| 10 | 2021 | 30 | |
| 11 | Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report | 2010 | 29 |
| 12 | 2018 | 28 | |
| 13 | Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest. | 2015 | 26 |
| 14 | 2019 | 22 | |
| 15 | Treatments for Localized Prostate Cancer: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation | 2011 | 21 |
| 16 | 2019 | 19 | |
| 17 | 2020 | 19 | |
| 18 | 2022 | 17 | |
| 19 | 2017 | 16 | |
| 20 | 2021 | 16 |
About Fu Ren
Fu Ren is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 65 papers that have together received 777 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (6 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (3 papers), Morphological variations and asymmetry (3 papers), Kruppel-like factors research (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (170 citations), Aging (16 citations), Geriatrics and Gerontology (23 citations), Molecular Biology (321 citations) and Oncology (86 citations). Fu Ren has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Changyong Li, Qingyun Du, Da-Hua Liu, Xinyue Ye, Ning Li, Chao Wu, Lihua Li, Shuang Pan, Xi Huang and Aimei Wang. Their work appears in journals such as International Journal of Oncology, ISPRS International Journal of Geo-Information, Scientific Reports, American Journal of Forensic Medicine & Pathology and New Journal of Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.